We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proteome Sciences Plc | LSE:PRM | London | Ordinary Share | GB0003104196 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.46 | 14.65% | 3.60 | 2.50 | 3.60 | 3.60 | 3.60 | 3.60 | 170,549 | 12:37:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 7.78M | 1.33M | 0.0045 | 8.00 | 10.63M |
Date | Subject | Author | Discuss |
---|---|---|---|
18/1/2024 11:56 | Now the US facility is up & running & with new plexing advances this year, coupled with movement on our stroke portfolio we should see increased revenue & a return to profitability this year. I’m certainly looking for 10p+ on the share price in 2024. Time will tell. W41 | wrighty41 | |
16/1/2024 08:33 | tbf it has only been like that for 5 years. | james japp | |
15/1/2024 12:13 | zombie share, no trades | elpirata | |
15/1/2024 12:12 | Well then *£53 a share here we come... *3p | coldale1 | |
13/1/2024 17:27 | They have stated a lot publicly over the years,all the way down from £2.40. | peverill | |
13/1/2024 16:24 | wasjobber many thanks | elpirata | |
13/1/2024 15:35 | 2023 AGM webinar | wasjobber | |
13/1/2024 14:54 | post the reference/link please wasjobber? | elpirata | |
13/1/2024 14:01 | Proteome Sciences have stated publicly that they plan to float on the New York stock exchange. | wasjobber | |
13/1/2024 13:40 | theres more chance of them floating on Cobham boating lake than nyse | elpirata | |
13/1/2024 12:49 | None of that changes the incredibly positive outlook for Proteome Sciences. Mass spec is the way forward and PRM are in a very attractive position. You can continue your negative views and miss the huge gains that will come as PRM progress. Let's see what happens when Proteome Sciences float on the New York stock exchange. Although by then, you and others will have missed the biggest gains. STRONG BUY | wasjobber | |
13/1/2024 11:42 | Can you keep the rampy stuff over on the other board please,we have heard it all before and where are we,oh yes 4p+ to buy,.Coming from a company claiming to work in a billion dollar industry that has captured 0.000000001% of it.Remember the research notes they used to release,???,nobody will touch them anymore. | peverill | |
13/1/2024 11:02 | The introduction of 32-plex TMTpro is an important milestone. It appears to be important for Thermo Scientific and Steven Gygi at Harvard University where PRM have close collaborations. "This proposal will develop new mass spectrometry-based technologies to allow sample multiplexing such that up to 32 clinical or experimental proteomes can be analyzed simultaneously. These technologies will revolutionize our ability to profile hundreds to thousands of individual samples .........." STRONG BUY | wasjobber | |
13/1/2024 00:16 | The new 32-plex TMT Pro reagents due to be released by Thermo Scientific in the next few months will have significant implications for mass spec proteomics. It will of course have a huge positive effect on Proteome Sciences profits, as the technology draws a much wider user base. It will become a very attractive option for all mass spec proteomics labs where large scale population testing becomes a reality. Also, there is the imminent release of the brand new 6-plex DIA isotopic reagents, which will add another swathe of new users to Proteome Sciences reagents portfolio, adding further significant revenues, including of course an initial licensing payment. | pools2 | |
12/1/2024 23:08 | I suspect you are on the goatvine and the rest of us are not. Anyway, I sincerely hope you are right! | small crow | |
12/1/2024 18:28 | "You omitted PRM's interest in Stroke - which I think will be bigger than TMT".Your local Coop outperforms TMT. | peverill | |
12/1/2024 18:10 | "I know the factors that will cause the price increase, but, alas, not the exact timing." Unfortunately, timing is everything. | small crow | |
12/1/2024 16:16 | If you wish to it is your prerogative. I really do not mind either way. But thank you for asking. | goatherd | |
12/1/2024 15:16 | would you like me to c & p your previous posts on timing goatherd, both kefi & here? | elpirata | |
12/1/2024 14:46 | #92631 ++++++ deluded avatar alert ++++++ | monte1 | |
12/1/2024 14:38 | elpirta, You omitted PRM's interest in Stroke - which I think will be bigger than TMT. I have got more than a clue about timing. You clearly have not. And don't forget PRM's vast library of patents. Someday, any day, someone may start infringing them. And when, that I do not have a clue about. | goatherd | |
12/1/2024 11:53 | Same as everyone else here then, what you mean is that you hope the kefi mine project (which exists on paper) will get funded, and PRM's latest TMT/biomarkers gestation will achieve enough commercial sales at margin to report a material profit which would benefit shareholders after the board have taken their annaul loot out. As for timing, you aint got a clue & are guessing what you want to believe | elpirata | |
12/1/2024 11:32 | Monte I never "shout" about anything. The two stocks I am "fondest" of - PRM & KEFI, will, I am very sure, come very, very good at some stage. KEFI probably before PRM. KEFI in weeks, or even days. Proteome in months, hopefully not years. I know the factors that will cause the price increase, but, alas, not the exact timing. | goatherd |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions